Thomas, H <br/><br/>
Proliferating cell nuclear antigen (PCNA) immunostaining--a prognostic factor in ovarian cancer?  [electronic resource] 

 -  British journal of cancer  Feb 1995 
 - 357-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1995.72  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--immunology<br/>Antigens, Neoplasm--analysis<br/>Biomarkers, Tumor--analysis<br/>Carboplatin--therapeutic use<br/>Cell Division<br/>Combined Modality Therapy<br/>England--epidemiology<br/>Female<br/>Humans<br/>Immunoenzyme Techniques<br/>Laparotomy<br/>Life Tables<br/>Middle Aged<br/>Neoplasm Staging<br/>Neoplasm, Residual<br/>Ovarian Neoplasms--chemistry<br/>Paraffin Embedding<br/>Prognosis<br/>Proliferating Cell Nuclear Antigen--analysis<br/>Radiotherapy, Adjuvant<br/>Survival Analysis